Filing Details
- Accession Number:
- 0000899243-18-002328
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-30 20:58:24
- Reporting Period:
- 2018-01-26
- Accepted Time:
- 2018-01-30 20:58:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1609809 | Seres Therapeutics Inc. | MCRB | Pharmaceutical Preparations (2834) | 274326290 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1643736 | Michele Trucksis | C/O Seres Therapeutics, Inc. 200 Sidney Street Cambridge MA 02139 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-01-26 | 7,500 | $0.00 | 7,500 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-01-26 | 2,607 | $11.02 | 4,893 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | RESTRICTED STOCK UNITS | Disposition | 2018-01-26 | 7,500 | $0.00 | 7,500 | $0.00 |
Common Stock | STOCK OPTION (RIGHT TO BUY) | Disposition | 2018-01-30 | 95,000 | $0.00 | 95,000 | $10.42 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,000 | No | 4 | M | Direct | ||
95,000 | 2028-01-29 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- These restricted stock units have vested and settled or will vest and settle as to 20% of the restricted stock units on January 26, 2018, 30% on January 26, 2019; and 50% on January 26, 2020.
- The Option will vest as to 25% of the shares on January 30, 2019. The remainder of the shares will vest in 12 equal quarterly installments thereafter.